NAPA, Calif., June 5, 2023 /PRNewswire/ — The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, is pleased to announce the appointment of Christa Steele, MBA, to its Board of Governors. Ms. Steele is a financial and governance executive with decades of corporate leadership experience across a wide range of industries. Ms. Steele currently serves on … Read more
The Dutch will be at BIO International Convention in Boston, June 5-8, 2023, to share how companies in the Netherlands are driving innovation that contributes to a healthier world WASHINGTON, June 5, 2023 /PRNewswire/ — The Netherlands is a prime location for biotech companies that bring forth an open-minded, innovative and inclusive approach to novel … Read more
In der ASCO Developmental Therapeutics – Immunotherapy Session präsentiert Dr. Howard Safran ermutigende Daten zur Phase 1/2-Studie von Dragonflys DF1001, einem immunologischen TriNKET®, das auf HER2 bei Patienten mit fortgeschrittenen soliden Tumoren abzielt. WALTHAM, Mass., 5. Juni 2023 /PRNewswire/ — Dragonfly Therapeutics, Inc., ein im klinischen Stadium tätiges Biotechnologieunternehmen, das neuartige Immuntherapien entwickelt, gibt die … Read more
SAN DIEGO, June 5, 2023 /PRNewswire/ — Wounded Warrior Project® (WWP) will collaborate with the Department of Veterans Affairs (VA) to host 140 veterans for the 16th annual National Veterans Summer Sports Clinic this week in San Diego. WWP is both sponsoring the event and leading the cycling portion of the clinic with staff members from the … Read more
At 16-months median follow-up, CARVYKTI® significantly improved progression-free survival compared to two standard treatments1 Data presented at the 2023 ASCO and EHA Annual Meetings and published in The New England Journal of Medicine CHICAGO, June 5, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that results from the Phase 3 … Read more
In the ASCO Developmental Therapeutics – Immunotherapy Session, Dr. Howard Safran presents encouraging data on Dragonfly’s phase 1/2 study of DF1001, an immune engaging TriNKET® targeting HER2 in patients with advanced solid tumors. WALTHAM, Mass., June 5, 2023 /PRNewswire/ — Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, announces the first presentation of … Read more
Former Cigna and Humana executive named chief operating officer of fast-growing, value-based specialty provider for patients with kidney and polychronic conditions NASHVILLE, Tenn., June 5, 2023 /PRNewswire/ — Monogram Health, a specialty provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney disease and related metabolic disorders, has hired Casey … Read more
CHICAGO, June 5, 2023 /PRNewswire/ — EVERSANA, a leading provider of commercial services to the global life sciences industry, today announced that its agency network, EVERSANA INTOUCH, has been named a five-category winner at the 2023 Clio Health Awards. The team earned one gold, one silver, and three bronze awards for work with The Chrysalis Initiative and … Read more
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., June 5, 2023 /PRNewswire/ — – The COVID-19 pandemic has had a limited impact on the global breast cancer therapeutics market and reports see substantial growth now that it has receded. The status of breast cancer as one of the most commonly occurring cancers in the world is expected … Read more
GRANITE CITY, Ill., June 5, 2023 /PRNewswire/ — Like lots of public transit systems, the St. Clair County, Illinois Transit District (SCCTD) had become the go-to option for many people facing some combination of homelessness and mental health or substance use disorders. Trains and transfer stations saw all-day riders, panhandling, and disruptive behavior. For this population, … Read more